← Back to headlines
Deutsche Bank Upgrades Merck to Buy, Sees Clear Path Beyond Keytruda Patent Cliff
Deutsche Bank has upgraded Merck (MRK) to a 'Buy' rating, expressing optimism about the company's future beyond the patent expiration of its key drug, Keytruda.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oil Jumps Above $100 After US-Iran Talks Fail
just now
Philippine Deputy Speaker Discusses Government Underspending
just now
Pangasinan and BFAR Partner for Salt Industry Development
just now
The oil price spike is sending mortgage rates higher too: Mortgage and refinance interest rates today, April 30, 2026
17m ago